News & Blog

MEC in Q2 2024

Truvian: Independent Study Highlights Robustness and Ease-of-Use of Truvian’s Blood Testing Platform in a Real-World Clinical Setting

Truvian featured in the WSJ: The Companies Realizing Theranos’s Failed Dream

Aspen Neuroscience: Study of ANPD001 Autologous Neuronal Cell Replacement Treatment Approach Published in Journal of Neurosurgery

Truvian Health raises $74M to bring blood testing to anyone, anywhere

SonoThera™ to Present Late Breakthrough Data at ISTH 2024 on Development of Nonviral Hemophilia A Gene Therapy Treatment

ProJenX Announces Receipt of $1M Hoffman ALS Clinical Trial Award from the ALS Association

Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting

Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)

MEC in Q1 2024